ABSTRACT
During the acute phase of HIV-1 infection, a strong readaptation occurs in the viral population. Our objective was to analyze the post-transmission mutations associated with escape to the cytotoxic immune response and its relationship with the progression of the infection. In this study, a total of 17 patients were enrolled during acute/early primary HIV infection and 8 subjects that were the HIV positive partner resulting in 8 transmission pairs. Genotyping of the genetic polymorphisms of HLA class I A and B was performed using PCR-SSOP. Viral RNA extraction was from plasma. 570 single Gag-gene amplifications were obtained by limiting-dilution RT-PCR. Epitope prediction was performed with NetMHC CBS prediction server for the 19 HLA-A and B alleles. Cytotoxic response prediction was performed by using the IEDB Analysis Resource. From our results, we deduce that the transmitted CTL / gag escape frequency in the founder virus was at least double compared to the post-transmission events. Additionally, by means of an algorithm that combines these frequencies, we observed that the founder viruses better adapted to the HLA A / B alleles of the recipient could contribute to a greater progression of the infection. Our results suggest that there is a large adaptation of HIV-1 to the HLA A / B alleles prevalent in our population. However, despite this adaptive advantage, the virus needs to make "readjustments" through new escape and compensatory mutations. Interestingly, according to our results, this readaptation could have a role in the progression of the infection.
Subject(s)
HIV Infections/virology , HIV-1/genetics , Adult , Alleles , Argentina , Computational Biology , Epitopes, T-Lymphocyte/genetics , Epitopes, T-Lymphocyte/immunology , Female , Genotype , HIV Infections/immunology , HIV-1/immunology , Humans , Male , Mutation/genetics , Mutation/immunology , RNA, Viral/genetics , RNA, Viral/immunology , T-Lymphocytes, Cytotoxic/immunology , gag Gene Products, Human Immunodeficiency Virus/genetics , gag Gene Products, Human Immunodeficiency Virus/immunologyABSTRACT
ANTECEDENTES: Los genotipos asociados con la alergia a la leche de vaca (ALV) son desconocidos. Aún no han podido ser replicados en poblaciones independientes, y podrían ser responsables de la marcada variabilidad de la respuesta clínica individual a las proteínas lácteas. OBJETIVO: Caracterizar haplogrupos, de la Región D-Loop del ADN mitocondrial, en un grupo de niños ALV, con el fin de arribar a un mejor conocimiento de la herencia biológica y genética en la etiología de la enfermedad. POBLACION Y METODO: Diseño: Análisis de mutaciones o variantes de la región D-loop del genoma mitocondrial. Población: 41 niños de ambos sexos de 0-2 años, 11 alérgicos ALV y 30 controles. (Río Cuarto, Córdoba, Argentina) Los pacientes ALV se dividieron, según la sintomatología que presentaban en 6 casos con Dermatitis Atópica (DA) + Enfermedad Gastrointestinal (EGI) y en 5 casos con Rinitis y Asma (RA). La Región D-Loop del genoma mitocondrial se amplificó por PCR. El análisis filogenético fue calculado usando el programa CLUSTAL OMEGA, the Neighbor-Joining, BLOSUM62, con los datos estudiados y grabados por Jukes-Cantor y luego con Kimura-2, programas específicos disponibles (software). RESULTADOS: Se encontró una mutación o variante nucleotídica no descripta T16519C en la transición de haplogrupos asociada a pacientes ALV con DA+EGI en 6/6 casos, comparados con 5/5 casos con RA que no la presentaron, mientras que en los controles se la observó solo en 6/30, p=0,0312; RR 2,900. CONCLUSIONES: Estos hallazgos sugieren que esta mutación probablemente aumente la posibilidad de padecer ALV asociada con DA+EGI. (AU)
BACKGROUND: Genotypes associated to cow's milk allergy (CMA) are unknown. They have not been replicated in independent populations, and could be responsible for the marked variability in individual clinical response to milk proteins. OBJECTIVE: To characterize haplogroups of the D-Loop region of mitochondrial DNA in a group of children allergic to cow's milk in order to arrive at a better understanding of biological and genetic heritability in the etiology of the disease. POPULATION AND METHOD: Design: Analysis of mutations or variants of the D-loop of mitochondrial genome region. Population: 41 children of both sexes from 0-2 years, 11 with CMA and 30 healthy subjects (controls). (Río Cuarto, Córdoba, Argentina). The CMA patients were divided according to the symptoms presenting in: 6 cases with Atopic Dermatitis (AD) + Gastrointestinal disease (GID) and in 5 cases with Rhinitis and Asthma (RA). The D-Loop Region of mitochondrial genome was amplified by PCR. Phylogenetic analysis was calculated using the program CLUSTAL OMEGA, the Neighbor-Joining, BLOSUM62, with studied and recorded by Jukes-Cantor data and then with Kimura-2, available specific programs (software). RESULTS: We found a non-descript mutation or variant nucleotide T16519C in the transition of haplogroups associated with CMA patients with AD+ GID in 6/6 cases, compared with 5/5 cases with RA that failed it, whereas in controls was observed it only in 6/30, p = 0, 0312 RR 2,900. CONCLUSIONS: These features suggest that this mutation probably increases the possibility of suffering CMA associated with AD + GID. (AU)
Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Milk Hypersensitivity/diagnosis , Milk Hypersensitivity/genetics , Genome, Mitochondrial/geneticsABSTRACT
Antecedentes. Los resultados de las investigaciones sobre la historia natural de la alergia a la leche de vaca (ALV) no han provisto aún, de un cuadro claro y consistente que ayude en la práctica al médico tratante. Objetivo. Identifi car los factores involucrados en el desarrollo de la enfermedad en lactantes pequeños, con el fi n de determinar perfi les específi cos e índices predictivos. Lugar de realización: Río Cuarto, Córdoba, Argentina. Diseño. Análisis observacional y retrospectivo. Población. 91 niños con diagnóstico de ALV y 91 controles, de ambos sexos, menores de 6 años. Método. Análisis de factores seleccionados de las historias clínicas, su relación individual con el diagnóstico (prueba X2, Odds Ratios, diferencias de medias) y su incidencia conjunta en la probabilidad de ser ALV para determinar perfi les (análisis de correspondencias múltiple y regresión logística). Elaboración de 3 índices predictivos basados en: odds ratios individuales, los correspondientes a la regresión logística y la identifi cación de criterios mayores y menores, con su respectiva evaluación de efectividad diagnóstica (sensibilidad, especifi cidad, valores predictivos y curva ROC). Resultados. Se encontró que la edad de inicio de los síntomas, el tipo de alimentación recibida hasta el 3er mes de vida, la exposición al humo de cigarrillo, los antecedentes alérgicos maternos y el tipo de manifestaciones clínicas con que comienza la ALV son factores que con mayor probabilidad inciden en su desarrollo. Conclusión. La utilidad de estos perfi les e índices predictivos radica en una temprana identifi cación de pacientes con riesgo de padecer ALV(AU)
Background: The results of the research on the natural history of allergy to cow's milk allergy (CMA) still have not provided a clear picture and consistent that in practice helps the attending physician. Objective: to identify the factors involved in the development of the disease in young infants, in order to determine specifi c profi les and predictive clinical indexes. Setting: Río Cuarto, Córdoba, Argentina. Design: observacional and retrospective analysis. Population: 91 children with a diagnosis of CMA and 91 controls, of both sexes, under the age of 6 years. Methods: analysis of selected factors of the clinical histories, their relationship with the individual diagnosis (test X2, Odds Ratios, differences in average) and their combined impact on the probability of being CMA to determine profi les (multiple correspondence analysis and logistic regression). Elaboration of 3 predictive indices based on: individual Odds Ratios, corresponding to the logistic regression and the identifi cation of greater and smaller criteria, with its respective evaluation of effectiveness diagnoses (predictive sensitivity, specifi city, values and ROC curve). Results: we found that the age of onset of symptoms, the type of feeding received until the 3rd month of life, exposure to cigarette smoke, the maternal allergy history and the type of clinical manifestations with that begins the CMA, are factors that most likely have an impact on its development. Conclusion: the utility of these profi les and predictive clinics indexes lies in an early identifi cation of patients at risk of CMA.(AU)
Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Milk Hypersensitivity , Breast-Milk Substitutes , Immunoglobulin ESubject(s)
Edema/pathology , Hemorrhage/pathology , Vasculitis/pathology , Biopsy , Female , Humans , Infant , Skin/pathologyABSTRACT
The seroprevalence of anti-Cytomegalovirus antibodies in a selected children population was studied by an enzyme-immunoassay (ELISA) prepared in our laboratory. Sera from 207 children from middle socio-economic classes were studied. Children were divided into the following groups: Group 1: cord sera (n = 87); Group 2: children aged 13 months to 6 years (n = 54); Group 3: children aged 6-15 years (n = 66). Overall seroprevalence was 46.3%. The seropositivity and ELISA index titers for the three groups were, respectively: Group 1, 55%, mean = 2.16; Group 2, 90.7%, mean = 5.15; Group 3, 59%, mean = 2.49. Group 2 exhibited higher seropositivity (p < 0.0001) and higher index titers (p < 0.0001) than the other two groups. These results suggests that primoinfection with Cytomegalovirus in this population occurs in children aged 13 months to 6 years (Group 2). However, the high percentage (55%) of cord blood without anti-Cytomegalovirus antibodies suggests a risk for congenital infection or primary infection for those newborn who required blood transfusions or were fed with bank milk. Further studies are needed to determine the impact of Cytomegalovirus infections in populations from different socio-economic classes, in congenital infections, the prevalence of antibodies in blood banks and their frequency in immunocompromised patients.
Subject(s)
Antibodies, Viral/analysis , Cytomegalovirus Infections/epidemiology , Cytomegalovirus/immunology , Adolescent , Argentina/epidemiology , Child , Child, Preschool , Cytomegalovirus Infections/transmission , Enzyme-Linked Immunosorbent Assay , Fetal Blood/immunology , Humans , Infant , PrevalenceABSTRACT
The seroprevalence of anti-Cytomegalovirus antibodies in a selected children population was studied by an enzyme-immunoassay (ELISA) prepared in our laboratory. Sera from 207 children from middle socio-economic classes were studied. Children were divided into the following groups: Group 1: cord sera (n = 87); Group 2: children aged 13 months to 6 years (n = 54); Group 3: children aged 6-15 years (n = 66). Overall seroprevalence was 46.3
. The seropositivity and ELISA index titers for the three groups were, respectively: Group 1, 55
, mean = 2.16; Group 2, 90.7
, mean = 5.15; Group 3, 59
, mean = 2.49. Group 2 exhibited higher seropositivity (p < 0.0001) and higher index titers (p < 0.0001) than the other two groups. These results suggests that primoinfection with Cytomegalovirus in this population occurs in children aged 13 months to 6 years (Group 2). However, the high percentage (55
) of cord blood without anti-Cytomegalovirus antibodies suggests a risk for congenital infection or primary infection for those newborn who required blood transfusions or were fed with bank milk. Further studies are needed to determine the impact of Cytomegalovirus infections in populations from different socio-economic classes, in congenital infections, the prevalence of antibodies in blood banks and their frequency in immunocompromised patients.
ABSTRACT
The seroprevalence of anti-Cytomegalovirus antibodies in a selected children population was studied by an enzyme-immunoassay (ELISA) prepared in our laboratory. Sera from 207 children from middle socio-economic classes were studied. Children were divided into the following groups: Group 1: cord sera (n = 87); Group 2: children aged 13 months to 6 years (n = 54); Group 3: children aged 6-15 years (n = 66). Overall seroprevalence was 46.3
. The seropositivity and ELISA index titers for the three groups were, respectively: Group 1, 55
, mean = 2.16; Group 2, 90.7
, mean = 5.15; Group 3, 59
, mean = 2.49. Group 2 exhibited higher seropositivity (p < 0.0001) and higher index titers (p < 0.0001) than the other two groups. These results suggests that primoinfection with Cytomegalovirus in this population occurs in children aged 13 months to 6 years (Group 2). However, the high percentage (55
) of cord blood without anti-Cytomegalovirus antibodies suggests a risk for congenital infection or primary infection for those newborn who required blood transfusions or were fed with bank milk. Further studies are needed to determine the impact of Cytomegalovirus infections in populations from different socio-economic classes, in congenital infections, the prevalence of antibodies in blood banks and their frequency in immunocompromised patients.
ABSTRACT
It is difficult to compare levels of bone loss in periodontal disease measured by periodontal probe and X-ray and to verify them versus surgical techniques. In fact, there are relatively few published reports on the subject. To this purpose the Authors describe their personal experience using plates equipped with guide tracks and center-film boxes with personalized bites. The suitability of the two methods (probe, intraoral X-ray) to determine levels of bone loss similar to those revealed by surgical verification was assessed on the basis of an analysis of the respective bone loss in 44 sites surrounding 19 dental elements. This method, which is accurate but time-consuming, demonstrated an broadly analogous underestimate (approx. 20%) using both preoperative probe and X-ray techniques in comparison to the true level of bone loss measured during surgery.